Associations of Current Cigarette, E-Cigarette, and Cannabis Use with Xerostomia.

IF 2 Q2 DENTISTRY, ORAL SURGERY & MEDICINE

JDR Clinical & Translational Research Pub Date : 2026-07-01 Epub Date: 2025-09-05 DOI:10.1177/23800844251364158

B W Chaffee

{"title":"Associations of Current Cigarette, E-Cigarette, and Cannabis Use with Xerostomia.","authors":"B W Chaffee","doi":"10.1177/23800844251364158","DOIUrl":null,"url":null,"abstract":"Objectives: This investigation aimed to examine the associations between xerostomia and the use of cigarettes, e-cigarettes, and cannabis in a nationally representative cross-sectional sample of adults.Methods: Data from the Population Assessment of Tobacco and Health Study included N = 29,721 United States adults (age ≥18 y) surveyed during 2022 to 2023 about xerostomia (experiencing dry mouth \"frequently\" or \"always\") and their use of 9 types of tobacco products and cannabis. Survey-weighted multivariable regression models estimated the associations of xerostomia with various specifications of cigarette, e-cigarette, and cannabis use, adjusted for sociodemographic and health status variables.Results: Overall, 9.7% of participants experienced xerostomia. In adjusted models, past 30-d use of cigarettes, e-cigarettes, and cannabis were each associated with greater odds of xerostomia. The daily use of cigarettes (adjusted odds ratio: 1.7; 95% confidence interval: 1.4, 2.0), e-cigarettes (1.8; 1.5, 2.2), and cannabis (2.1; 1.7, 2.7) was also associated with greater odds of xerostomia. The greatest odds of xerostomia was associated with the use of all 3 products in combination within the past 30 d (3.8; 2.8, 5.2).Conclusions: The use of cigarettes, e-cigarettes, or cannabis, particularly when used together, is associated with a greater occurrence of oral dryness among adults. Among other adverse health effects of these products, potential xerostomia risk may encourage cessation, contribute to dental patient advising, and inform appropriate tobacco and cannabis regulations and policies.Knowledge Transfer Statement:Based on the findings of this study, dental professionals and patients should anticipate a higher prevalence of xerostomia among adults who use cigarettes, e-cigarettes, and/or cannabis. Dental professionals should incorporate this information into xerostomia management, treatment planning, and the guidance and cessation support provided to patients who use these products. Potential adverse oral health effects should be considered in tobacco and cannabis policies and regulations.","PeriodicalId":14783,"journal":{"name":"JDR Clinical & Translational Research","volume":" ","pages":"484-492"},"PeriodicalIF":2.0000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JDR Clinical & Translational Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23800844251364158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: This investigation aimed to examine the associations between xerostomia and the use of cigarettes, e-cigarettes, and cannabis in a nationally representative cross-sectional sample of adults.

Methods: Data from the Population Assessment of Tobacco and Health Study included N = 29,721 United States adults (age ≥18 y) surveyed during 2022 to 2023 about xerostomia (experiencing dry mouth "frequently" or "always") and their use of 9 types of tobacco products and cannabis. Survey-weighted multivariable regression models estimated the associations of xerostomia with various specifications of cigarette, e-cigarette, and cannabis use, adjusted for sociodemographic and health status variables.

Results: Overall, 9.7% of participants experienced xerostomia. In adjusted models, past 30-d use of cigarettes, e-cigarettes, and cannabis were each associated with greater odds of xerostomia. The daily use of cigarettes (adjusted odds ratio: 1.7; 95% confidence interval: 1.4, 2.0), e-cigarettes (1.8; 1.5, 2.2), and cannabis (2.1; 1.7, 2.7) was also associated with greater odds of xerostomia. The greatest odds of xerostomia was associated with the use of all 3 products in combination within the past 30 d (3.8; 2.8, 5.2).

Conclusions: The use of cigarettes, e-cigarettes, or cannabis, particularly when used together, is associated with a greater occurrence of oral dryness among adults. Among other adverse health effects of these products, potential xerostomia risk may encourage cessation, contribute to dental patient advising, and inform appropriate tobacco and cannabis regulations and policies.Knowledge Transfer Statement:Based on the findings of this study, dental professionals and patients should anticipate a higher prevalence of xerostomia among adults who use cigarettes, e-cigarettes, and/or cannabis. Dental professionals should incorporate this information into xerostomia management, treatment planning, and the guidance and cessation support provided to patients who use these products. Potential adverse oral health effects should be considered in tobacco and cannabis policies and regulations.

查看原文本刊更多论文

当前香烟、电子烟和大麻使用与口干症的关系。

目的：本研究旨在研究在全国代表性的成年人横断面样本中，口干症与香烟、电子烟和大麻的使用之间的关系。方法：来自烟草与健康人口评估研究的数据包括N = 29,721名美国成年人（年龄≥18岁），在2022年至2023年期间接受了关于口干（“经常”或“总是”经历口干）及其使用9种烟草制品和大麻的调查。调查加权的多变量回归模型估计了口干症与各种规格的香烟、电子烟和大麻的使用之间的关系，并根据社会人口统计学和健康状况变量进行了调整。结果：总体而言，9.7%的参与者经历了口干症。在调整后的模型中，过去30天使用香烟、电子烟和大麻的人患口干症的几率都更高。每日使用香烟（校正优势比：1.7；95%可信区间：1.4,2.0）、电子烟（1.8,1.5,2.2）和大麻（2.1,1.7,2.7）也与口干的几率较高相关。在过去30天内联合使用所有3种产品的患者发生口干的几率最大（3.8;2.8,5.2）。结论：香烟、电子烟或大麻的使用，特别是同时使用时，与成人口腔干燥的发生率增加有关。在这些产品的其他不利健康影响中，潜在的口干风险可能鼓励戒烟，有助于向牙科患者提供咨询，并告知适当的烟草和大麻法规和政策。知识转移声明：根据这项研究的发现，牙科专业人员和患者应该预测使用香烟、电子烟和/或大麻的成年人中口干症的患病率更高。牙科专业人员应将这些信息纳入口干症的管理、治疗计划，并为使用这些产品的患者提供指导和戒烟支持。在烟草和大麻政策和条例中应考虑到潜在的不利口腔健康影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JDR Clinical & Translational Research DENTISTRY, ORAL SURGERY & MEDICINE-

CiteScore

6.20

自引率

6.70%

发文量

期刊介绍： JDR Clinical & Translational Research seeks to publish the highest quality research articles on clinical and translational research including all of the dental specialties and implantology. Examples include behavioral sciences, cariology, oral & pharyngeal cancer, disease diagnostics, evidence based health care delivery, human genetics, health services research, periodontal diseases, oral medicine, radiology, and pathology. The JDR Clinical & Translational Research expands on its research content by including high-impact health care and global oral health policy statements and systematic reviews of clinical concepts affecting clinical practice. Unique to the JDR Clinical & Translational Research are advances in clinical and translational medicine articles created to focus on research with an immediate potential to affect clinical therapy outcomes.